Hiroshi Uchi Selected Research

Hiroshi Uchi Research Topics

Disease

37	Melanoma (Melanoma, Malignant) 03/2024 - 01/2006
32	Neoplasms (Cancer) 12/2023 - 01/2006
15	Atopic Dermatitis (Atopic Eczema) 06/2018 - 12/2003
9	Inflammation (Inflammations) 02/2019 - 03/2002
9	Yusho Disease 08/2015 - 04/2011
8	Poisoning 02/2018 - 10/2008
7	Skin Diseases (Skin Disease) 01/2018 - 11/2007
6	Neoplasm Metastasis (Metastasis) 01/2021 - 07/2013
6	Squamous Cell Carcinoma (Epidermoid Carcinoma) 10/2020 - 11/2007
6	Extramammary Paget Disease (Paget Disease, Extramammary) 06/2016 - 01/2007
5	Psoriasis (Pustulosis Palmaris et Plantaris) 02/2019 - 03/2006
5	Disease Progression 10/2018 - 03/2006
5	Wasting Syndrome (Wasting Disease) 05/2015 - 01/2012
5	Carcinogenesis 12/2013 - 05/2005
4	Hemangiosarcoma (Angiosarcoma) 01/2018 - 10/2007
3	Skin Ulcer 12/2019 - 04/2015
3	Wounds and Injuries (Trauma) 12/2019 - 10/2017
3	Eczema 06/2018 - 03/2011
3	Vitiligo 06/2017 - 01/2006
3	Foodborne Diseases 10/2015 - 10/2009
2	Basal Cell Carcinoma (Rodent Ulcer) 09/2022 - 11/2007
2	Dermatitis 02/2019 - 06/2018
2	Adrenal Insufficiency (Adrenal Gland Hypofunction) 01/2019 - 05/2017
2	Necrosis 01/2018 - 05/2012
2	Fever (Fevers) 01/2018 - 11/2014
2	Edema (Dropsy) 08/2017 - 03/2002
2	Acne Vulgaris 01/2017 - 04/2011
2	Birth Weight (Birth Weights) 01/2015 - 01/2012
2	Cough 11/2014 - 10/2008
2	Lichen Planus (Lichen Ruber Planus) 03/2014 - 10/2009
2	Carcinoma (Carcinomatosis) 07/2013 - 06/2013
2	Fatigue 01/2011 - 10/2008
2	Neurofibrosarcoma (MPNST) 09/2010 - 06/2010
2	Arthralgia (Joint Pain) 05/2009 - 10/2008
2	Contact Dermatitis (Eczema, Contact) 06/2003 - 03/2002
1	Acute Generalized Exanthematous Pustulosis 01/2020
1	Chloracne 07/2018
1	Venous Thrombosis (Deep-Vein Thrombosis) 07/2018

Drug/Important Bio-Agent (IBA)

19	NivolumabIBA 01/2023 - 07/2016
18	DioxinsIBA 07/2018 - 05/2009
10	Polychlorinated Biphenyls (PCBs)IBA 02/2018 - 05/2008
9	Immune Checkpoint InhibitorsIBA 12/2023 - 05/2017
9	Proteins (Proteins, Gene)FDA Link 06/2018 - 03/2006
8	IpilimumabIBA 01/2023 - 01/2018
8	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 07/2018 - 01/2012
6	pembrolizumabIBA 03/2024 - 01/2017
6	AntibodiesIBA 08/2022 - 05/2005
6	Polychlorinated Dibenzodioxins (TCDD)IBA 02/2018 - 01/2012
5	Biomarkers (Surrogate Marker)IBA 11/2019 - 05/2017
4	Monoclonal AntibodiesIBA 10/2020 - 01/2017
4	Cytochrome P-450 CYP1A1 (CYP1A1)IBA 07/2018 - 01/2012
4	Immunoglobulin E (IgE)IBA 04/2011 - 09/2008
3	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 12/2023 - 01/2021
3	6-formylindolo(3,2-b)carbazoleIBA 02/2019 - 10/2017
3	Programmed Cell Death 1 ReceptorIBA 01/2019 - 01/2018
3	Filaggrin ProteinsIBA 06/2018 - 10/2014
3	Rice Bran OilIBA 02/2018 - 10/2008
3	Polychlorinated DibenzofuransIBA 02/2018 - 10/2008
3	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 10/2017 - 05/2006
3	CytokinesIBA 05/2017 - 01/2011
3	Cathepsin KIBA 01/2011 - 05/2010
2	dabrafenibIBA 12/2021 - 07/2018
2	trametinibIBA 12/2021 - 07/2018
2	SteroidsIBA 01/2019 - 03/2006
2	Adrenocorticotropic Hormone (ACTH)FDA Link 01/2019 - 05/2017
2	Ointments (Pastes)IBA 12/2018 - 06/2018
2	cinnamaldehyde (cinnamic aldehyde)FDA Link 07/2018 - 01/2017
2	LigandsIBA 06/2018 - 06/2017
2	InterleukinsIBA 01/2018 - 03/2011
2	Dacarbazine (DIC)FDA LinkGeneric 08/2017 - 07/2016
2	InterferonsIBA 05/2017 - 03/2011
2	dibenzofuranIBA 05/2015 - 04/2011
2	S100 Proteins (S 100 Protein)IBA 12/2013 - 10/2008
2	ChemokinesIBA 10/2013 - 09/2007
2	2,3,4,7,8-pentachlorodibenzofuranIBA 08/2013 - 10/2008
2	Cadherins (E-Cadherin)IBA 07/2013 - 01/2007
2	Interleukin-22 (IL-22)IBA 01/2011 - 01/2011
2	Substance PIBA 01/2011 - 12/2010
2	matrigelIBA 01/2011 - 12/2010
2	NF-kappa B (NF-kB)IBA 10/2009 - 03/2007
2	p38 Mitogen-Activated Protein KinasesIBA 10/2009 - 03/2007
2	CholesterolIBA 05/2009 - 10/2008
2	Cyclin D1IBA 10/2007 - 03/2007
2	Tacrolimus (Prograf)FDA LinkGeneric 03/2006 - 07/2004
2	CX 659SIBA 06/2003 - 03/2002
1	5-((glucopyranosyloxy)methyl)uracilIBA 09/2022
1	indirubinIBA 12/2019
1	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 11/2019
1	GlucocorticoidsIBA 01/2019
1	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2019
1	Glucagon-Like Peptide 1 (GLP 1)IBA 12/2018
1	Liraglutide FDA Link 12/2018
1	Glucagon-Like Peptide-1 ReceptorIBA 12/2018
1	keishibukuryoganIBA 07/2018
1	anti-thyroglobulinIBA 06/2018
1	Peroxidase (Myeloperoxidase)IBA 06/2018

Therapy/Procedure

22	Therapeutics 03/2024 - 07/2004
5	Immunotherapy 01/2023 - 01/2018
4	Drug Therapy (Chemotherapy) 11/2020 - 06/2016
2	Kampo Medicine (Kampo) 07/2018 - 01/2011